Free Trial

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.06 0.00 (0.00%)
As of 09:40 AM Eastern

LABS vs. HLS, SUGR, TGOD, NINE, MDP, WMD, VM, WLLW, HEXO, and VIR

Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include HLS Therapeutics (HLS), SugarBud Craft Growers (SUGR), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Medexus Pharmaceuticals (MDP), WeedMD (WMD), Voyageur Pharmaceuticals (VM), Willow Biosciences (WLLW), HEXO (HEXO), and Viridium Pacific Group (VIR). These companies are all part of the "drug manufacturers - specialty & generic" industry.

MediPharm Labs vs. Its Competitors

HLS Therapeutics (TSE:HLS) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by insiders. Comparatively, 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

HLS Therapeutics presently has a consensus price target of C$4.50, suggesting a potential downside of 8.16%. Given HLS Therapeutics' stronger consensus rating and higher probable upside, equities research analysts plainly believe HLS Therapeutics is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HLS Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

MediPharm Labs has a net margin of -30.56% compared to HLS Therapeutics' net margin of -38.70%. MediPharm Labs' return on equity of -24.41% beat HLS Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
HLS Therapeutics-38.70% -25.27% -2.89%
MediPharm Labs -30.56%-24.41%-7.17%

In the previous week, HLS Therapeutics' average media sentiment score of 0.00 equaled MediPharm Labs'average media sentiment score.

Company Overall Sentiment
HLS Therapeutics Neutral
MediPharm Labs Neutral

MediPharm Labs has lower revenue, but higher earnings than HLS Therapeutics. HLS Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HLS TherapeuticsC$40.13M2.72-C$15.53M-C$1.00-4.91
MediPharm LabsC$39.42M0.68-C$12.05M-C$0.03-2.24

HLS Therapeutics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.

Summary

HLS Therapeutics beats MediPharm Labs on 7 of the 13 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$26.98MC$2.16BC$5.53BC$6.18B
Dividend YieldN/A2.92%5.25%6.72%
P/E Ratio-2.244.1727.0254.57
Price / Sales0.68558.81431.591,154.91
Price / Cash1.3010.3536.8283.29
Price / Book0.5911.708.074.65
Net Income-C$12.05MC$21.15BC$3.17BC$301.20M
7 Day PerformanceN/A1.71%3.83%0.61%
1 Month PerformanceN/A6.38%3.56%3.49%
1 Year PerformanceN/A3.98%34.27%27.37%

MediPharm Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.07
flat
N/A-7.1%C$26.98MC$39.42M-2.24130
HLS
HLS Therapeutics
0.4452 of 5 stars
C$4.80
+0.2%
C$4.50
-6.3%
+39.0%C$106.79MC$40.13M-4.8191High Trading Volume
SUGR
SugarBud Craft Growers
N/AC$13.40
+1.1%
N/A+73.3%C$91.39MC$575.64M16.1444News Coverage
Gap Down
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940Gap Up
MDP
Medexus Pharmaceuticals
1.873 of 5 stars
C$3.17
+0.6%
C$5.49
+73.1%
+20.4%C$70.97MC$100.25M15.1698
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
VM
Voyageur Pharmaceuticals
N/AC$0.33
-2.9%
N/A+480.0%C$50.00MN/A-30.87N/A
WLLW
Willow Biosciences
N/AC$0.30
+11.1%
N/A+125.0%C$43.45MC$2.94M-5.4919Gap Up
HEXO
HEXO
N/AN/AN/AN/AC$38.72MC$124.10M-0.26690
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up

Related Companies and Tools


This page (TSE:LABS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners